Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Jury awards $18 million to two Accutane side effects victims

Filed July 3rd, 2012 Laurie

Two former Accutane acne medication users have been awarded $18 million by a jury in New Jersey after agreeing that the makers of the drug failed to warn of its serious side effects.

The two Plaintiffs represented in the case each developed a severe bowel disorder that’s completely changed their way of life. They blame the once-popular acne medication Accutane for causing their disease and say the drug’s maker, Roche Holding AG, failed to warn of this side effect.

Each Plaintiff was awarded $9 million for the injuries caused by their inflammatory bowel disease. Accutane was pulled from the market by Roche after jurors had previous awarded millions of dollars to other victims of the drug’s hidden side effects.

In the same case, jurors rejected the claims of two other Plaintiffs who made similar claims. Roche said it plans to appeal the losses handed to it by the New Jersey jury. If the decisions hold, it will mark the eighth and ninth cases from 13 in which a jury decided Accutane and Roche’s failure to warn of inflammatory bowel disease side effects led to their injuries.

As many as 16 million people took Accutane while it was on the market, from 1982 until 2009. A warning about its link to inflammatory bowel diseases like Crohn’s disease and ulcerative colitis was not added to its safety label until 2005.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!